Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Peripheral Blood Stem Cell Transplantation: early-phase trial registry
1 of 3 indexed Peripheral Blood Stem Cell Transplantation trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Peripheral Blood Stem Cell Transplantation: 3 US clinical trials tracked, 1 recruiting.
Peripheral Blood Stem Cell Transplantation is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is The University of Texas Health Science Center at San Antonio, running 1 of these trials.
Enrollment posture brief
Registry condition peripheral-blood-stem-cell-transplantation
OPEN 1 | RECR 33% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Peripheral Blood Stem Cell Transplantation lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Peripheral Blood Stem Cell Transplantation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Peripheral Blood Stem Cell Transplantation is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
National Cancer Institute (NCI)
NCT05436418
Incidence and Factors Associated With the Development and Severity of Oral Mucositis
The University of Texas Health Science Center at San Antonio
NCT00575809
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
University of Florida
NCT02398708
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Peripheral Blood Stem Cell Transplantation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Peripheral Blood Stem Cell Transplantation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Peripheral Blood Stem Cell Transplantation page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Peripheral Blood Stem Cell Transplantation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- The University of Texas Health Science Center at San Antonio sponsors the most Peripheral Blood Stem Cell Transplantation trials on record, review their full trial history before evaluating a specific study. See The University of Texas Health Science Center at San Antonio's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripheral Blood Stem Cell Transplantation condition card totals 3 registered trials; most-linked intervention Clinical data; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.